A new group of P *-chiral bisdiamidophosphites has been developed for Pd- and Rh-catalyzed asymmetric reactions with good to excellent enantioselectivities.
No takes yet. Share an insight, caveat, or question.
Gavrilov et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: